Search

Your search keyword '"Javier Gómez-Vera"' showing total 32 results

Search Constraints

Start Over You searched for: Author "Javier Gómez-Vera" Remove constraint Author: "Javier Gómez-Vera"
32 results on '"Javier Gómez-Vera"'

Search Results

1. Executive Summary of ARIA 2019: Integrated care pathways for allergic rhinitis in Argentina, Spain and Mexico

2. GUIMIT 2019, Mexican Guideline on Immunotherapy. Guideline on the diagnosis of IgE-mediated allergic disease and immunotherapy following the ADAPTE approach

3. MASK (Mobile Airways Sentinel Network), a mobile App with ARIA’s comprehensive solution in Spanish-speaking countries

4. Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelinesBox 1. Clinical questions (1.1.3, 1.1.8, 1.2.4, 1.2.5)∗Box 2. Clinical question (4.1.1, 4.3.4)∗Box 3. Clinical questions (5.1.1–5.1.4)∗Box 4. Clinical questions (4.a.4a-d, 4.3.6, 4.3.7)∗

5. Mexican consensus on the diagnosis and treatment of atopic dermatitis in adolescents and adults

6. Mexican Asthma Guidelines: GUIMA 2017

7. Mexican Guidelines on the Diagnosis and Treatment of Urticaria

9. Recomendaciones de los Expertos para la Concientización del Asma en México

10. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly ( <scp>MACVIA</scp> ‐ <scp>ARIA</scp> ) ‐ <scp>EIP</scp> on <scp>AHA</scp> Twinning Reference Site ( <scp>GARD</scp> research demonstration project)

11. MASK (Mobile Airways Sentinel Network), una app móvil con la solución integral de ARIA en países de habla hispana

12. Resumen ejecutivo de ARIA 2019: Vías integradas de atención para la rinitis alérgica en Argentina, España y México

13. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

14. Pediatric asthma treatment: What to do when international guideline recommendations do not agree

15. Juvenile rheumatoid arthritis and asthma, but not childhood-onset systemic lupus erythematosus are associated with FCRL3 polymorphisms in Mexicans

16. Omalizumab in the treatment of antihistamine-resistant chronic urticaria in adults

17. Pediatric asthma treatment

18. Tumor necrosis factor–α is a common genetic risk factor for asthma, juvenile rheumatoid arthritis, and systemic lupus erythematosus in a Mexican pediatric population

19. [Mexican guidelines on the diagnosis and treatment of urticaria]

20. [Risk factors associated with the development of atopic march. Case-control study]

21. NFE2L2 gene variants and susceptibility to childhood-onset asthma

22. [Association between chronic urticaria and Helicobacter pylori]

23. [Inflammatory mediators in patients with atopic dermatitis after treatment with transfer factor]

24. [Pulse oxymetry in the diagnosis of asthma in children]

25. [Airway hyperreactivity in patients with allergic and non-allergic rhinitis]

26. [Psychological, immunological, and endocrinological implications of atopic dermatitis]

27. [Gastroesophageal reflux disease in pediatric patients with asthma]

28. 274 Vasculitic Urticaria Treated with Omalizumab. Case Report

29. 139 Genetic Association Study of the IgE Immunodeficiency in Mexican Population

30. 269 Refractory Chronic Urticaria Treated with Omalizumab

31. 279 Near-Fatal Asthma Treated with Omalizumab

32. Transfer factor and allergy

Catalog

Books, media, physical & digital resources